Total Payments
$608.33
2024 Payments
$394.53
Companies
11
Transactions
41
Medicare Patients
577
Medicare Billing
$37,768
Payment Breakdown by Category
Food & Beverage$608.33 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $608.33 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $214.51 | 17 | $0 (2024) |
| Lilly USA, LLC | $121.64 | 8 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $73.52 | 4 | $0 (2024) |
| Novo Nordisk Inc | $47.09 | 3 | $0 (2024) |
| Amgen Inc. | $40.88 | 3 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $24.93 | 1 | $0 (2024) |
| Exact Sciences Corporation | $21.33 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $18.30 | 1 | $0 (2019) |
| PFIZER INC. | $16.29 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.97 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $394.53 | 28 | ABBVIE INC. ($162.86) |
| 2023 | $150.93 | 9 | AbbVie Inc. ($51.65) |
| 2022 | $44.57 | 3 | Lilly USA, LLC ($44.57) |
| 2019 | $18.30 | 1 | Merck Sharp & Dohme Corporation ($18.30) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Obesity | ||||||
| 10/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: PAIN | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.09 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Respiratory | ||||||
| 06/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Inflammation | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: NEUROSCIENCE | ||||||
| 04/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 501 | 885 | $57,509 | $29,016 |
| 2022 | 2 | 37 | 37 | $10,781 | $4,554 |
| 2021 | 2 | 39 | 39 | $41,069 | $4,198 |
Total Patients
577
Total Services
961
Medicare Billing
$37,768
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 70 | 130 | $21,725 | $11,985 | 55.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $13,060 | $6,590 | 50.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 48 | $6,600 | $3,120 | 47.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 26 | 26 | $3,770 | $2,004 | 53.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 40 | 45 | $2,510 | $1,378 | 54.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $3,455 | $1,315 | 38.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 39 | 92 | $3,336 | $928.73 | 27.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 70 | 86 | $1,290 | $654.46 | 50.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 32 | 34 | $680.00 | $550.80 | 81.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 43 | 52 | $388.00 | $353.64 | 91.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 15 | 17 | $255.00 | $66.98 | 26.3% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 31 | 154 | $308.00 | $57.38 | 18.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 27 | 132 | $132.00 | $12.45 | 9.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $7,539 | $3,471 | 46.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 13 | 13 | $3,242 | $1,084 | 33.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 25 | 25 | $17,785 | $2,217 | 12.5% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 14 | 14 | $23,284 | $1,981 | 8.5% |
About Dr. Amy Traylor, MD
Dr. Amy Traylor, MD is a Family Medicine healthcare provider based in Haleyville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1972000149.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Traylor, MD has received a total of $608.33 in payments from pharmaceutical and medical device companies, with $394.53 received in 2024. These payments were reported across 41 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($608.33).
As a Medicare-enrolled provider, Traylor has provided services to 577 Medicare beneficiaries, totaling 961 services with total Medicare billing of $37,768. Data is available for 3 years (2021–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Haleyville, AL
- Active Since 04/12/2018
- Last Updated 03/29/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972000149
Products in Payments
- VRAYLAR (Drug) $191.17
- MOUNJARO (Drug) $77.07
- BREZTRI (Drug) $49.20
- Wegovy (Drug) $47.09
- Otezla (Drug) $40.88
- Qelbree (Drug) $24.93
- FARXIGA (Drug) $24.32
- Cologuard Collection Kit (Device) $21.33
- JARDIANCE (Drug) $18.44
- NEXPLANON (Drug) $18.30
- NURTEC ODT (Drug) $16.29
- TRINTELLIX (Drug) $15.97
- TRELEGY ELLIPTA (Drug) $13.87
- TRULICITY (Drug) $13.09
- EMGALITY (Drug) $13.04
- UBRELVY (Drug) $11.75
- QULIPTA (Drug) $11.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Haleyville
Mr. Boyde Harrison, Md, MD
Family Medicine — Payments: $53,662
Family Medicine $53,662
Vanessa Ragland, D.o, D.O
Family Medicine — Payments: $2,969
Family Medicine $2,969
Jeffrey Long, D.o, D.O
Family Medicine — Payments: $2,037
Family Medicine $2,037
Elena Roumaya, M.d, M.D
Family Medicine — Payments: $277.27
Family Medicine $277.27
Hank Lee, M.d, M.D
Family Medicine — Payments: $117.64
Family Medicine $117.64
Dillon Tate, Nurse Practitioner, NURSE PRACTITIONER
Family Medicine — Payments: $110.01
Family Medicine $110.01